Science and Enterprise

Tag: Israel

  • Medical Device Company Gets $20M in Venture Financing

    Ornim Inc., a developer of blood oxygen and blood flow monitors in Lod, Israel, secured $20 million in series B venture funding, the second financing cycle after initial start-up. The round was led by life sciences investment firm OrbiMed, with participants including the GE healthymagination Fund and Agate Medical Investments LP. Ornim develops monitors focusing…

  • Model, Software Find Minerals in Mountain Ranges

    A geophysicist at Tel Aviv University in Israel has developed modeling techniques and associated software for discovering minerals in mountain ranges, which are difficult to survey for mining opportunities. Lev Eppelbaum, a professor in the university’s geophysics and planetary sciences department, presented his methods in a paper at a meeting of the European Geosciences Union…

  • Biopharma Secures $38.5 Million in Series D Funds

    Chiasma Inc., a biopharmaceutical company in Jerusalem, Israel, has closed its $38.5 million series D funding round, the fourth cycle of financing after initial start-up. The round was led by by new investor Abingworth and current investor MPM Capital, with participation from current share holders 7 Med Health Ventures, ARCH Venture Partners, F3 Ventures, and…

  • Israeli Consortium to Study Mediterranean Resources

    A consortium of universities and research institutes, headed by University of Haifa, will establish the Israel Center for Mediterranean Sea Research. A committee of Israel’s Council for Higher Education adopted the recommendation of Israel Academy of Sciences to establish the center, whose work will include research of Israel’s off-shore economic potential. In addition to University…

  • Non-Invasive Hemoglobin Anemia Screening System Unveiled

    OrSense Ltd., a medical device developer in Israel, has introduced a wireless, non-invasive hemoglobin measurement system for anemia monitoring, hemorrhage detection, and pre-donation blood screening. The company revealed the new product at a meeting of the International Society of Blood Transfusion in Cancun, Mexico. Hemoglobin is a protein in red blood cells that carries oxygen.…

  • Merck Serono, Compugen to Form Toxicity Biomarkers Start-Up

    Merck Serono, a division of the global pharmaceutical company Merck in Geneva, Switzerland and the drug discovery company Compugen in Tel Aviv, Israel have agreed to form Neviah Genomics, a new enterprise to develop biomarkers for the prediction of drug-induced toxicity. While some financial arrangements were revealed, the total value of the deal was not…

  • Venture Fund to Invest $442M in Europe, U.S. Start-Ups

    The venture capital company Index Ventures, based in London, unveiled a €350 million ($442 million) fund to invest largely in start-up technology companies. The company expects to focus its new investments on European enterprises, but include start-ups in the U.S. and Israel as well. Index Ventures plans to concentrate on seed and early-stage investments in…

  • Robotic-Guided Brain Surgery Performed

    Mazor Robotics Ltd. in Caesarea, Israel says it completed three robot-guided brain surgical procedures with its technology. The nature of the procedures was not disclosed. The procedures were performed by neurosurgeons In-Se Kim and Robert Schönmayr at Horst Schmidt Kliniken in Wiesbaden, Germany. Mazor Robotics is a developer of robotics for spinal surgery, often involving…

  • Biomaterials Developer Lands $10 Million Series C Funds

    Regentis Biomaterials Ltd., based in Or Akiva, Israel and Princeton, New Jersey, has secured $10 million in series C funds, the third round of financing after initial start-up. New investors Royal DSM and Crossroad Fund, and existing investors Medica Venture Partners, SCPVitalife and the Technion Investment Opportunities Fund contributed to the round. The company’s lead…

  • Biotech Licenses Brain-Nervous System Treatment Technology

    Ben-Gurion University of the Negev in Israel says it has licensed a technology from its labs that crosses the blood-brain barrier to deliver drugs for treating disorders of the brain and central nervous system. The V-Smart technology, as its called, was licensed exclusively to Lauren Sciences LLC, a privately held biotechnology company in New York.…